Alliancebernstein L.P. Regeneron Pharmaceuticals, Inc. Transaction History

Alliancebernstein L.P.

  • $290 Billion
  • Q2 2025

A detailed history of Alliancebernstein L.P. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 587,227 shares of REGN stock, worth $383 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
587,227
Previous 609,608 3.67%
Holding current value
$383 Million
Previous $387 Million 20.26%
% of portfolio
0.11%
Previous 0.15%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$483.07 - $625.6 $10.8 Million - $14 Million
-22,381 Reduced 3.67%
587,227 $308 Million
Q1 2025

May 15, 2025
SELL
$634.14 - $744.83 $8.59 Million - $10.1 Million
-13,548 Reduced 2.17%
609,608 $387 Million
Q4 2024

Feb 12, 2025
BUY
$701.85 - $1046.91 $30.6 Million - $45.7 Million
43,638 Added 7.53%
623,156 $444 Million
Q3 2024

Nov 14, 2024
SELL
$1024.09 - $1201.76 $118 Million - $139 Million
-115,579 Reduced 16.63%
579,518 $609 Million
Q2 2024

Aug 14, 2024
SELL
$883.2 - $1071.19 $36.6 Million - $44.4 Million
-41,436 Reduced 5.63%
695,097 $731 Million
Q1 2024

May 14, 2024
SELL
$902.69 - $993.35 $6.94 Million - $7.63 Million
-7,684 Reduced 1.03%
736,533 $709 Million
Q4 2023

Feb 14, 2024
BUY
$775.18 - $881.7 $40.3 Million - $45.8 Million
51,959 Added 7.51%
744,217 $654 Million
Q3 2023

Nov 14, 2023
BUY
$692.45 - $844.37 $3.05 Million - $3.71 Million
4,399 Added 0.64%
692,258 $570 Million
Q2 2023

Aug 15, 2023
BUY
$700.03 - $830.35 $52.5 Million - $62.3 Million
74,973 Added 12.23%
687,859 $494 Million
Q1 2023

May 15, 2023
BUY
$680.49 - $826.97 $5.25 Million - $6.37 Million
7,708 Added 1.27%
612,886 $504 Million
Q4 2022

Feb 14, 2023
SELL
$705.89 - $766.39 $34 Million - $36.9 Million
-48,195 Reduced 7.38%
605,178 $437 Million
Q3 2022

Nov 15, 2022
SELL
$573.97 - $724.32 $385,707 - $486,743
-672 Reduced 0.1%
653,373 $450 Million
Q2 2022

Aug 15, 2022
BUY
$548.35 - $738.84 $41.8 Million - $56.3 Million
76,176 Added 13.18%
654,045 $387 Million
Q1 2022

May 13, 2022
BUY
$595.12 - $698.43 $4.61 Million - $5.41 Million
7,749 Added 1.36%
577,869 $404 Million
Q4 2021

Feb 14, 2022
BUY
$543.48 - $670.97 $37.2 Million - $45.9 Million
68,434 Added 13.64%
570,120 $360 Million
Q3 2021

Nov 10, 2021
SELL
$574.03 - $680.96 $217 Million - $258 Million
-378,465 Reduced 43.0%
501,686 $304 Million
Q2 2021

Jul 30, 2021
SELL
$472.8 - $558.54 $566 Million - $669 Million
-1,197,100 Reduced 57.63%
880,151 $492 Million
Q1 2021

May 06, 2021
BUY
$446.73 - $548.2 $140 Million - $172 Million
313,907 Added 17.8%
2,077,251 $983 Million
Q4 2020

Feb 08, 2021
BUY
$478.3 - $607.98 $99.9 Million - $127 Million
208,936 Added 13.44%
1,763,344 $852 Million
Q3 2020

Nov 12, 2020
BUY
$544.75 - $658.21 $6.35 Million - $7.68 Million
11,662 Added 0.76%
1,554,408 $870 Million
Q2 2020

Aug 13, 2020
SELL
$493.32 - $643.92 $139 Million - $181 Million
-281,790 Reduced 15.44%
1,542,746 $962 Million
Q1 2020

May 14, 2020
SELL
$336.18 - $494.43 $43 Million - $63.3 Million
-128,021 Reduced 6.56%
1,824,536 $891 Million
Q4 2019

Feb 18, 2020
SELL
$274.13 - $376.51 $47.2 Million - $64.8 Million
-172,219 Reduced 8.11%
1,952,557 $733 Million
Q3 2019

Nov 14, 2019
BUY
$273.46 - $318.39 $164 Million - $191 Million
599,187 Added 39.28%
2,124,776 $589 Million
Q2 2019

Aug 14, 2019
BUY
$299.6 - $414.82 $112 Million - $154 Million
372,238 Added 32.27%
1,525,589 $478 Million
Q1 2019

May 14, 2019
SELL
$372.08 - $439.57 $38.8 Million - $45.9 Million
-104,355 Reduced 8.3%
1,153,351 $474 Million
Q4 2018

Feb 13, 2019
BUY
$335.82 - $403.04 $78.6 Million - $94.4 Million
234,112 Added 22.87%
1,257,706 $470 Million
Q3 2018

Nov 08, 2018
BUY
$351.14 - $408.51 $94.7 Million - $110 Million
269,696 Added 35.77%
1,023,594 $414 Million
Q2 2018

Aug 13, 2018
BUY
$284.6 - $344.99 $152 Million - $184 Million
533,434 Added 241.96%
753,898 $260 Million
Q1 2018

May 14, 2018
SELL
$315.82 - $393.78 $3.37 Million - $4.21 Million
-10,681 Reduced 4.62%
220,464 $75.9 Million
Q4 2017

Feb 13, 2018
BUY
$358.63 - $469.95 $4.06 Million - $5.32 Million
11,324 Added 5.15%
231,145 $86.9 Million
Q3 2017

Nov 13, 2017
BUY
$431.38 - $504.0 $94.8 Million - $111 Million
219,821
219,821 $98.3 Million

Others Institutions Holding REGN

# of Institutions
1,439
Shares Held
88.9M
Call Options Held
1.98M
Put Options Held
1.75M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $69.9B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email